JSB Market Research: Xalkori (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022

Michaeldellk22 2014-06-24

Views 10

Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy.

Share This Video


Download

  
Report form
RELATED VIDEOS